Gene, cell, and RNA therapy startup financing quarterly 2023
This statistic shows the quarterly start-up financing for gene, cell, and RNA therapy companies from Q4 2021 to Q1 2024. Start-up financing in Q1 2024 involving gene, cell, and RNA therapy companies stood at some 240 million U.S. dollars, the lowest amount in the provided period.